VKTX

VIKING THERAPEUTICS INC

Healthcare | Mid Cap

-$0.90

EPS Forecast

$15.26

Revenue Forecast

Announcing earnings for the quarter ending 2025-12-31T00:00:00 soon
NRXPNrx Pharmaceuticals IncGALTGalectin Therapeutics IncEBSEmergent Biosolutions IncXOMAXoma Royalty CorpFBIOFortress Biotech Inc